Most Recent
After signalling last month they were close to resolving their trade mark dispute, real estate companies RE/MAX and Resimax have been been given one last chance -- and one more week -- to settle.
The Full Federal Court will hear arguments next week in an appeal by the ACCC over an alleged laundry detergent cartel, the first so-called hub and spoke case brought by the competition regulator.
A casual worker hired as a truck driver at a Rio Tinto coal mine was entitled to annual leave, the Full Federal Court said Friday in a landmark judgement that says employees on predictable, regular shifts are not casual even when employers give them the designation.
The ACCC will decide by November 8 whether the proposed merger of Nine Entertainment with Fairfax Media raises competition concerns.
The applicant in a consumer class action against Radio Rentals has lost her bid for interrogatories which an attorney for the class said could lend support to claims that the company's "strange" lease contracts were structured to avoid its obligations under the Uniform Consumer Credit Code.
The Construction, Forestry, Maritime, Mining and Energy Union and its ACT branch secretary have been hit with criminal charges that they engaged in a cartel for steelfixing and scaffolding services.
Top AFL and NRL clubs have agreed to change their refunds and returns policies on football and rugby merchandise after an investigation by the ACCC found they were in breach of the Australian Consumer Law.
Chicken processor Inghams has won an appeal of a ruling that put it on the hook for the late-night assault of a shift worker in the car park of the company's poultry plant in Murarrie, Queensland.
The judge overseeing the competition lawsuit brought by the ACCC over Aurizon's proposed sale of its Queensland intermodal business to Pacific National has denied the regulator's bid for an injunction against Pacific, saying it amounted to micro-managing that could discourage "normal competitive behaviour".
Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.